Nanjing Vazyme Biotech Co Ltd Cash Flow Reinvestment Rate
Nanjing Vazyme Biotech Co Ltd cash flow reinvestment rate. Nanjing Vazyme Biotech Co Ltd (688105) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥15.83 Million (capex CN¥15.83 Million ) from operating cash flow of CN¥75.30 Million. Explore 688105 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Nanjing Vazyme Biotech Co Ltd (2019–2025)
Cash flow reinvestment rate of Nanjing Vazyme Biotech Co Ltd from 2019 to 2025. Historical reinvestment intensity for Nanjing Vazyme Biotech Co Ltd across 6 annual periods. Explore Nanjing Vazyme Biotech Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Nanjing Vazyme Biotech Co Ltd Cash Flow Reinvestment Rate by Year (2019–2025)
Nanjing Vazyme Biotech Co Ltd cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Nanjing Vazyme Biotech Co Ltd. For the full cash flow conversion analysis, see Nanjing Vazyme Biotech Co Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.39x | CN¥323.20 Million | CN¥233.16 Million | CN¥47.39 Million | ▼ -75.7% |
| 2023 | 5.71x | CN¥1.13 Billion | CN¥198.40 Million | CN¥232.90 Million | ▲ +119.3% |
| 2022 | 2.61x | CN¥1.92 Billion | CN¥735.17 Million | CN¥962.86 Million | ▼ -4.9% |
| 2021 | 2.74x | CN¥1.69 Billion | CN¥616.80 Million | CN¥261.96 Million | ▲ +102.8% |
| 2020 | 1.35x | CN¥1.09 Billion | CN¥803.55 Million | CN¥152.54 Million | ▼ -36.0% |
| 2019 | 2.11x | CN¥32.08 Million | CN¥15.20 Million | CN¥19.88 Million | — |